AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. EBITDA margin (%)

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥11.6B
P/E ratio
58x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 2025-0.4-112.62%
Mar 31, 20242.8-58.82%
Mar 31, 20236.8+24.46%
Mar 31, 20225.4-279.07%
Mar 31, 2021-3-37.46%
Mar 31, 2020-4.9-776.28%
Mar 31, 20190.7-82.71%
Mar 31, 20184.2-39.65%
Mar 31, 20176.9-7.06%
Mar 31, 20167.4-17.87%
Mar 31, 20159

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)